Director exercised or converted 8,750 CYTK derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Dec 2, 2025
- Reporting period
- Not applicable
- Filed with the SEC
- Dec 2, 2025
DirectorOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001061983-25-000042
Added to OQROOct 6, 2026, 7:14 PM UTC Data qualityVerified: identifiers matched exactly Reporting personJohn T Henderson SecurityNon-Qualified Stock Option (Right to Buy) TableDerivative (Table II) Transaction dateDec 2, 2025 Acquired / disposedDisposed (D) Around the same time
Officer sold ~$113K of Cytokinetics
Automatic saleCompensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.